• 1
    Surveillance Epidemiology and End Results (SEER) Program. Cancer Statistics Review. Bethesda, MD: National Cancer Institute, 2009.
  • 2
    Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998; 83: 1664-1678.
  • 3
    Bonett A, Roder D, Esterman A. Epidemiological features of melanoma in South Australia: implications for cancer control. Med J Aust. 1989; 151:502-504, 506-509.
  • 4
    Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of california cancer registry data, 1988-93. Cancer Causes Control. 1997; 8: 246-252.
  • 5
    Hersey P, Sillar RW, Howe CG, et al. Factors related to the presentation of patients with thick primary melanomas. Med J Aust. 1991; 154: 583-587.
  • 6
    Hanrahan PF, Hersey P, D'Este CA. Factors involved in presentation of older people with thick melanoma. Med J Aust 1998; 169: 410-414.
  • 7
    Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994; 86: 761-769.
  • 8
    Van Durme DJ, Ferrante JM, Pal N, Wathington D, Roetzheim RG, Gonzalez EC. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med. 2000; 9: 606-611.
  • 9
    Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol. 1994; 1: 487-494.
  • 10
    Goodwin JS, Samet JM, Key CR, Humble C, Kutvirt D, Hunt C. Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc. 1986; 34: 20-26.
  • 11
    Hanrahan PF, Hersey P, Watson AB, Callaghan TM. The effect of an educational brochure on knowledge and early detection of melanoma. Aust J Public Health. 1995; 19: 270-274.
  • 12
    Holmes FF, Hearne E3rd., Cancer stage-to-age relationship: implications for cancer screening in the elderly. J Am Geriatr Soc. 1981; 29: 55-57.
  • 13
    Roder DM, Luke CG, McCaul KA, Esterman AJ. Trends in prognostic factors of melanoma in South Australia, 1981-1992: implications for health promotion. Med J Aust. 1995; 162: 25-29.
  • 14
    Geller AC, Miller DR, Lew RA, Clapp RW, Wenneker MB, Koh HK. Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts. Am J Public Health. 1996; 86: 538-543.
  • 15
    Vagero D, Persson G. Risks, survival and trends of malignant melanoma among white and blue collar workers in Sweden. Soc Sci Med. 1984; 19: 475-478.
  • 16
    Swetter SM, Johnson TM, Miller DR, Layton CJ, Brooks KR, Geller AC. Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol. 2009; 145: 397-404.
  • 17
    Vayer A, Lefor AT. Cutaneous melanoma in African-Americans. South Med J. 1993; 86: 181-182.
  • 18
    Koh HK, Sober AJ, Day CLJr, Lew RA, Fitzpatrick TB. Cigarette smoking and malignant melanoma. Prognostic implications. Cancer. 1984; 53: 2570-2573.
  • 19
    Rigel DS, Friedman RJ, Levine J, Kopf AW, Levenstein M. Cigarette smoking and malignant melanoma. Prognostic implications. J Dermatol Surg Oncol. 1981; 7: 889-891.
  • 20
    Dintenfass L. Effect of smoking on the recurrence of malignant melanoma. Med J Aust. 1979; 1: 620.
  • 21
    Shaw HM, Milton GW, McCarthy WH, Farago GA, Dilworth P. Effect of smoking on the recurrence of malignant melanoma. Med J Aust. 1979; 1: 208-209.
  • 22
    Shaw HM, Milton GW. Smoking and the development of metastases from malignant melanoma. Int J Cancer. 1981; 28: 153-156.
  • 23
    Roetzheim RG, Pal N, van Durme DJ, et al. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol. 2000; 43: 211-218.
  • 24
    Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst. 1999; 91: 1409-1415.
  • 25
    Geller AC, Johnson TM, Miller DR, Brooks KR, Layton CJ, Swetter SM. Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol. 2009; 145: 409-414.
  • 26
    Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 2005; 53: 393-406.
  • 27
    McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006; 54: 783-792.
  • 28
    Brady MS, Oliveria SA, Christos PJ, et al. Patterns of detection in patients with cutaneous melanoma. Cancer. 2000; 89: 342-347.
  • 29
    Vercelli M, Lillini R, Capocaccia R, et al. Cancer survival in the elderly: effects of socio-economic factors and health care system features (ELDCARE project). Eur J Cancer. 2006; 42: 234-242.
  • 30
    De Boer MF, Ryckman RM, Pruyn JF, Van den Borne HW. Psychosocial correlates of cancer relapse and survival: a literature review. Patient Educ Couns. 1999; 37: 215-30.
  • 31
    de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer. 2001; 37: 332-339.
  • 32
    Hansen RP, Olesen F, Sorensen HT, Sokolowski I, Sondergaard J. Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res. 2008; 8: 49.
  • 33
    Lai H, Lai S, Krongrad A, Trapido E, Page JB, McCoy CB. The effect of marital status on survival in late-stage cancer patients: an analysis based on surveillance, epidemiology, and end results (SEER) data, in the United States. Int J Behav Med. 1999; 6: 150-176.
  • 34
    Reyes Ortiz CA, Freeman JL, Kuo YF, Goodwin JS. The influence of marital status on stage at diagnosis and survival of older persons with melanoma. J Gerontol A Biol Sci Med Sci. 2007; 62: 892-898.
  • 35
    National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database: Incidence—SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying)—Linked to County Attributes–Total U.S., 1969-2006 Counties: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, April 2009, based on November 2008 submission.
  • 36
    Frey CM, McMillen MM, Cowan CD, Horm JW, Kessler LG. Representativeness of the surveillance, epidemiology, and end results program data: recent trends in cancer mortality rates. J Natl Cancer Inst. 1992; 84: 872-877.
  • 37
    Merrill RM, Dearden KA. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control. 2004; 15: 1027-1034.
  • 38
    Surveillance Epidemiology and End Results (SEER) Program. About SEER. Bethesda, MD: National Cancer Institute; 2009.
  • 39
    Reyes-Ortiz CA, Goodwin JS, Freeman JL, Kuo YF. Socioeconomic status and survival in older patients with melanoma. J Am Geriatr Soc. 2006; 54: 1758-1764.
  • 40
    . World Health Organization. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 41
    Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. Journal of clinical oncology: official journal of the Am Soc Clin Oncol. 2008; 26: 66-75.
  • 42
    Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989; 129: 125-137.
  • 43
    Swetter SM, Layton CJ, Johnson TM, Brooks KR, Miller DR, Geller AC. Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses. Arch Dermatol. 2009; 145: 488-490.
  • 44
    Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001; 19: 3622-3634.
  • 45
    American Cancer Society, Cancer Facts & Figures 2009. Atlanta, GA: American Cancer Society, Inc.; 2009.
  • 46
    MacKinnon JA, Duncan RC, Huang Y, Lee DJ, Fleming LE, Voti L, et al. Detecting an association between socioeconomic status and late stage breast cancer using spatial analysis and area-based measures. Cancer Epidemiol Biomarkers Prev. 2007; 16: 756-762.
  • 47
    Fisher J, Engelhardt HS, Stephens JA, et al. Cancer-related disparities among residents of Appalachia Ohio. J Health Dispar Res Pract. 2008; 2: 61-74.
  • 48
    Hart LG, Larson EH, Lishner DM. Rural definitions for health policy and research. Am J Public Health. 2005; 95: 1149-1155.
  • 49
    Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol. 1992; 26: 914-919.